Page last updated: 2024-08-26

sivelestat and Carcinoma, Hepatocellular

sivelestat has been researched along with Carcinoma, Hepatocellular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akamoto, S; Izuishi, K; Okano, K; Sano, T; Suzuki, Y; Usuki, H; Wakabayashi, H; Yachida, S	1

Trials

1 trial(s) available for sivelestat and Carcinoma, Hepatocellular

Article	Year
Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery. Surgery today, 2007, Volume: 37, Issue:5 Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Digestive System Neoplasms; Digestive System Surgical Procedures; Esophageal Neoplasms; Esophagectomy; Female; Glycine; Humans; Interleukin-6; Leukocyte Elastase; Liver Neoplasms; Male; Middle Aged; Pancreaticoduodenectomy; Postoperative Period; Prospective Studies; Serine Proteinase Inhibitors; Single-Blind Method; Stress, Physiological; Sulfonamides; Th1 Cells; Th2 Cells	2007

Article

Year

Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery.

Surgery today, 2007, Volume: 37, Issue:5

Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Digestive System Neoplasms; Digestive System Surgical Procedures; Esophageal Neoplasms; Esophagectomy; Female; Glycine; Humans; Interleukin-6; Leukocyte Elastase; Liver Neoplasms; Male; Middle Aged; Pancreaticoduodenectomy; Postoperative Period; Prospective Studies; Serine Proteinase Inhibitors; Single-Blind Method; Stress, Physiological; Sulfonamides; Th1 Cells; Th2 Cells

2007